Get started
Author

Takahiro Kojima

Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
2021 · Evan Y Yu, Daniel P Petrylak, et al. · The Lancet Oncology · 289
Support System of Cystoscopic Diagnosis for Bladder Cancer Based on Artificial Intelligence
2019 · Atsushi Ikeda, Hirokazu Nosato, et al. · Journal of Endourology · 120
Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling
2008 · T Kojima, T Shimazui, et al. · Oncogene · 92
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab
2020 · Takashi Kobayashi, Katsuhiro Ito, et al. · Cancer Science · 69
PDF
Genome-wide identification of endothelial cell–enriched genes in the mouse embryo
2012 · Haruka Takase, Ken Matsumoto, et al. · Blood · 67
PDF
Overview of current and future systemic therapy for metastatic renal cell carcinoma
2019 · Takahiro Osawa, Ario Takeuchi, et al. · Japanese Journal of Clinical Oncology · 57
Japanese subgroup analysis of EV‐301: An open‐label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinoma
2022 · Nobuaki Matsubara, Junji Yonese, et al. · Cancer Medicine · 55
Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients
2020 · Masaki Shiota, Naoki Terada, et al. · Cancer Science · 44
PDF
Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR
2021 · Takashi Kobayashi, Katsuhiro Ito, et al. · Cancer Immunology Immunotherapy · 40
Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motility
2014 · MASAHIKO TAMEDA, KAZUSHI SUGIMOTO, et al. · International Journal of Oncology · 40
PDF
Cystoscopic Imaging for Bladder Cancer Detection Based on Stepwise Organic Transfer Learning with a Pretrained Convolutional Neural Network
2020 · Atsushi Ikeda, Hirokazu Nosato, et al. · Journal of Endourology · 39
Biomarkers for precision medicine in bladder cancer
2016 · Takahiro Kojima, Koji Kawai, et al. · International Journal of Clinical Oncology · 39
ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma
2021 · Ken Tanaka, Shuya Kandori, et al. · Oncology Reports · 38
PDF
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis
2021 · Mizuki Kobayashi, Shintaro Narita, et al. · British Journal of Urology · 35
Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future
2020 · Tomokazu Kimura, Hitoshi Ishikawa, et al. · Japanese Journal of Clinical Oncology · 35
FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma
2010 · Takahiro Kojima, Toru Shimazui, et al. · Genes Chromosomes and Cancer · 35
Epidermoid cyst of an intrapancreatic accessory spleen--a case report.
2000 · S Tsutsumi, T Kojima, et al. · PubMed · 35
ELOVL5 ‐mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma
2022 · Satoshi Nitta, Shuya Kandori, et al. · Cancer Science · 34
Phase I/IIa PET imaging study with 89zirconium labeled anti-PSMA minibody for urological malignancies
2018 · Akira Joraku, Kentaro Hatano, et al. · Annals of Nuclear Medicine · 33
Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor
2014 · Masahiro Kurobe, Koji Kawai, et al. · Journal of Cancer Research and Clinical Oncology · 30
PDF
PLD1 promotes tumor invasion by regulation of MMP-13 expression via NF-κB signaling in bladder cancer
2021 · Yoshiyuki Nagumo, Shuya Kandori, et al. · Cancer Letters · 29
The updated points of TNM classification of urological cancers in the 8th edition of AJCC and UICC
2019 · Shuya Kandori, Takahiro Kojima, et al. · Japanese Journal of Clinical Oncology · 29
Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin
2018 · Shuya Kandori, Takahiro Kojima, et al. · Cancer Science · 29
PDF
Non-maintenance intravesical Bacillus Calmette–Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study
2021 · on behalf of the Japanese Urological Oncology Group, Makito Miyake, et al. · BMC Cancer · 28
PDF
TRPV4-dependent induction of a novel mammalian cold-inducible protein SRSF5 as well as CIRP and RBM3
2017 · Takanori Fujita, Hiroaki Higashitsuji, et al. · Scientific Reports · 28
PDF
Works count: 250
Citation count: 2,591
H-index: 26
I10-index: 76
Year
Topic
Type